imipramine has been researched along with Libman-Sacks Disease in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugiyama, T | 1 |
| Kiwamoto, H | 1 |
| Esa, A | 1 |
| Park, YC | 1 |
| Kaneko, S | 1 |
| Kurita, T | 1 |
1 other study available for imipramine and Libman-Sacks Disease
| Article | Year |
|---|---|
[Neurogenic bladder in patients with SLE].
Topics: Adolescent; Female; Humans; Imipramine; Lupus Erythematosus, Systemic; Middle Aged; Myelitis, Transv | 1987 |